Table 9 Multivariate analysis of the correlation between side effects, stage, and parity with the risk of treatment interruption with P
Side Effect | "p" Value of Univariate Analysis | Univariate Analysis OR (CI) | "p" Value of Adjusted Analysis | Adjusted Analysis OR (CI) |
|---|---|---|---|---|
Duration of Treatment Less than 9 Months | < 0.001 | 5.625 (2.410–13.130) | < 0.001 | 9.398 (3.006–29.378) |
Spotting | 0.057 | 1.775 (0.984–3.203) | 0.024 | 2.638 (1.134–6.136) |
Weight Gain | 0.073 | 2.405 (0.923–6.271) | 0.211 | 2.110 (0.655–6.796) |
Intense Bleeding | 0.086 | 4.062 (0.821–20.104) | 0.308 | 3.443 (0.319–37.174) |
Staging Minimal/Mild | 0.005 | 5.206 (1.654–16.382) | 0.001 | 8.078 (2.291–28.482) |
Nulliparity | 0.171 | 1.538 (0.830–2.852) | 0.239 | 1.667 (0.711–3.907) |